Spain Virtual Clinical Trials Market Size & Outlook
- HC Outsourcing
- Clinical Trials
- Virtual Clinical Trials Market Outlook
- Clinical Trials
Global Market
Related Markets
Ask Prism AI about the virtual clinical trials market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Spain virtual clinical trials market highlights
- The Spain virtual clinical trials market generated a revenue of USD 184.3 million in 2023 and is expected to reach USD 277.3 million by 2030.
- The Spain market is expected to grow at a CAGR of 6% from 2024 to 2030.
- In terms of segment, interventional was the largest revenue generating study design in 2023.
- Expanded Access is the most lucrative study design segment registering the fastest growth during the forecast period.
Virtual clinical trials market data book summary
| Market revenue in 2023 | USD 184.3 million |
| Market revenue in 2030 | USD 277.3 million |
| Growth rate | 6% (CAGR from 2024 to 2030) |
| Largest segment | Interventional |
| Fastest growing segment | Expanded Access |
| Historical data | 2017 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Interventional, Observational, Expanded Access |
| Key market players worldwide | Icon PLC, PAREXEL, IQVIA Holdings Inc, Labcorp Holdings Inc, LEO Pharma, Medidata, Oracle Corp, Signant Health |
Other key industry trends
- In terms of revenue, Spain accounted for 2.1% of the global virtual clinical trials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany virtual clinical trials market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 329.4 million by 2030.
Rising incidence & prevalence of chronic diseases and increasing number of people suffering from diabetes are among the major factors contributing to market growth in Spain.
According to a report published by the Healthdata Organization in 2017, diseases such as ischemic heart diseases and lung cancer have a high prevalence rate in the country, thereby boosting the demand for virtual clinical trials in this country.
Moreover, according to the International Diabetes Federation, in Spain, the prevalence rate of diabetes in adults was ~10.4%, and about 3,584,500 cases of diabetes were reported in 2017. These factors are likely to drive market growth in the country during the forecast period.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Virtual Clinical Trials Market Scope
Virtual Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Oracle Corp | View profile | 164,000 | 2300 Oracle Way, Austin, TX, United States, 78741 | www.oracle.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Icon PLC | View profile | 41,150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | www.iconplc.com |
| LEO Pharma | View profile | 1001-5000 | Parsippany, New Jersey, United States, North America | www.leo-pharma.us/ |
| IQVIA Holdings Inc | View profile | 87,000 | 2400 Ellis Road, Durham, NC, United States, 27703 | www.iqvia.com |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.parexel.com |
| Medidata | View profile | 1001-5000 | New York, New York, United States, North America | www.medidata.com |
| Signant Health | View profile | 1001-5000 | Blue Bell, Pennsylvania, United States, North America | www.signanthealth.com/ |
Spain Virtual Clinical Trials Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Virtual Clinical Trials Market Outlook will help companies and investors design strategic landscapes.
Interventional was the largest segment with a revenue share of 49.76% in 2023.
Horizon Databook has segmented the Spain virtual clinical trials market based on interventional, observational, expanded access covering the revenue growth of each sub-segment from 2017 to 2030.
Rising incidence & prevalence of chronic diseases and increasing number of people suffering from diabetes are among the major factors contributing to market growth in Spain.
According to a report published by the Healthdata Organization in 2017, diseases such as ischemic heart diseases and lung cancer have a high prevalence rate in the country, thereby boosting the demand for virtual clinical trials in this country.
Moreover, according to the International Diabetes Federation, in Spain, the prevalence rate of diabetes in adults was ~10.4%, and about 3,584,500 cases of diabetes were reported in 2017. These factors are likely to drive market growth in the country during the forecast period.
- Spain Virtual Clinical Trials Market Study Design Outlook (Revenue, USD Million , 2018-2030)
- Interventional
- Observational
- Expanded Access
- Spain Virtual Clinical Trials Market Indication Outlook (Revenue, USD Million , 2018-2030)
- Oncology
- Cardiovascular
- Others
Reasons to subscribe to Virtual Clinical Trials Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Virtual Clinical Trials Market Outlook databook
- Our clientele includes a mix of Virtual Clinical Trials Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain Virtual Clinical Trials Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Spain Virtual Clinical Trials Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Spain Virtual Clinical Trials Market, 2018-2030 (US$M)
Spain virtual clinical trials market statistics, by study design, 2017-2030 (US$M)
